Image

Digital Epidemiology Study on Brain Functioning

Recruiting
7 - 12 years of age
Both
Phase N/A

Powered by AI

Overview

Neurobiology has improved the integrative understanding of brain development. With digital technologies, digital (bio)markers would be relevant variables for a better understanding of the heterogeneity of cognitive and behavioral functioning in developing children.

However, the dominant statistical approach of group comparison tends to ignore intragroup variability. Applying high-dimensional data sets through multivariate methods and then combining their scores via predictive model learning algorithms would allow the identification of subtypes. Thus, EPIDIA4KIDS wants to understand the brain functioning of children aged 7 to 12 years old from heterogeneous data sources collected from a touchscreen tablet.

Description

The overall objective of the EPIDIA4KIDS study is to understand brain functioning in children aged 7 to 12 years from heterogeneous digital data collected with a touch tablet. The investigators want to develop a digital e-screening, similarly to a blood test result, for cognitive, emotional and behavioral performances in children from 7 to 12 years old, resulting from a multimodal and multi-stream analysis generated by an artificial intelligence algorithm.

The main aims are therefore to:

  • Develop a normative base of cognitive, emotional and, behavioral performances with children aged 7 to 12 years old using our digital tool.
  • Examine the validity of our e-assessment by comparing the generated results to those obtained with standard measures of convergent validity.

Eligibility

Inclusion Criteria:

  • Boys or girls
  • Aged 7 to 12 years
  • Fluent in the French language
  • Agreement and signature of informed consent by the child
  • Agreement and signature of informed consent by one of the legal representatives
  • Estimated intelligence quotient > 85

Exclusion Criteria:

  • No biological parent or legal guardian is able to give permission for the minor and agrees to participate in parental assessments
  • Prematurity or other perinatal complications that required significant intervention
  • History of neurological disorders, including seizure disorders, cerebral palsy, or other conditions requiring neurological or medical care :
  • History of head injury:
    • Head trauma more than one year old with loss of consciousness >30 minutes, OR
    • Had to be hospitalized for head trauma, OR
    • Amnesia > 24 hours, OR
    • Confusion or loss of orientation >24 hours, OR
    • A brain scan revealed problems following a head injury, OR
    • Head trauma within the past year with loss of consciousness >10 minutes. Current or persistent major Axis I psychiatric disorder that may interfere with successful completion of the protocol (e.g., psychosis and bipolar disorder), or substance use disorder.
        Current use of medications with significant effects on brain function or blood flow (e.g.,
        antipsychotics, mood stabilizers); Attention Deficit Hyperactivity Disorder (ADHD)
        medications and Selective Serotonin Reuptake Inhibitors (SSRIs) are not excluded as the use
        of these medications is associated with certain neurodevelopmental disorders and assessment
        of these individuals will provide useful data to the community Not fluent in French (all
        youth materials are in French) Uncorrectable visual, hearing, or sensorimotor impairment,
        as the protocol items may not be valid.

Study details

Child Development, Child Development Disorder

NCT05577533

O-Kidia

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.